↓ Skip to main content

Dove Medical Press

Switching treatments in COPD: implications for costs and treatment adherence

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, December 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#28 of 2,577)
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
7 news outlets
policy
1 policy source
twitter
4 X users

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
102 Mendeley
Title
Switching treatments in COPD: implications for costs and treatment adherence
Published in
International Journal of Chronic Obstructive Pulmonary Disease, December 2015
DOI 10.2147/copd.s79635
Pubmed ID
Authors

Fulvio Braido, Federico Lavorini, Francesco Blasi, Ilaria Baiardini, Giorgio Walter Canonica

Abstract

Inhaled therapy is key to the management of chronic obstructive pulmonary disease (COPD). New drugs and inhalers have recently been launched or will soon become available, and the expiry of patent protection covering several currently used inhaled bronchodilators and corticosteroids will be accompanied by the development of bioequivalent, generic inhaled drugs. Consequently, a broader availability of branded and generic compounds will increase prescription opportunities. Given the time course of COPD, patients are likely to switch drugs and inhalers in daily practice. Switching from one device to another, if not accompanied by appropriate training for the patient, can be associated with poor clinical outcomes and increased use of health care resources. In fact, while it seems reasonable to prescribe generic inhaled drugs to reduce costs, inadequate use of inhaler devices, which is often associated with a poor patient-physician or patient-pharmacist relationship, is one of the most common reasons for failure to achieve COPD treatment outcomes. Further research is needed to quantify, as in asthma, the impact of inappropriate switching of inhalers in patients with COPD and show the outcomes related to the effect of using the same device for delivering inhaled medications.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 102 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 102 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 18%
Other 17 17%
Student > Ph. D. Student 13 13%
Student > Master 12 12%
Student > Bachelor 10 10%
Other 16 16%
Unknown 16 16%
Readers by discipline Count As %
Medicine and Dentistry 35 34%
Pharmacology, Toxicology and Pharmaceutical Science 17 17%
Nursing and Health Professions 9 9%
Economics, Econometrics and Finance 4 4%
Social Sciences 4 4%
Other 9 9%
Unknown 24 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 57. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2021.
All research outputs
#737,835
of 25,371,288 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#28
of 2,577 outputs
Outputs of similar age
#12,288
of 395,411 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#1
of 52 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,577 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 395,411 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.